Skip to Content

Notice

Manufacturer of Controlled Substances; Notice of Registration

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

By Notice dated March 14, 2003, and published in the Federal Register on April 2, 2003, (68 FR 16089), Mallinckrodt, Inc., Mallinckrodt & Second Streets, St. Louis, Missouri 63147, made application by renewal to the Drug Enforcement Administration for registration as a bulk manufacturer of the basic classes of controlled substances listed below:

DrugSchedule
Tetrahydrocannabinols (7370)I
Codeine-N-oxide (9053)I
Dihydromorphine (9145)I
Dihydromorphine (9145)I
Difenoxin (9168)I
Heroin (9200)I
Morphine-N-oxide (9307)I
Nicomorphine (9312)I
Normorphine (9313)I
Norlevorphanol (9634)I
Amphetamine (1100)II
Methamphetamine (1105)II
Methylphenidate (1724)II
Codeine (9050)II
Diprenorphine (9058)II
Etorphine HCL (9059)II
Dihydrocodeine (9120)II
Hydromorphone (9150)II
Oxycodone (9143)II
Diphenoxylate (9170)II
Benzoylecgonine (9180)II
Hydrocodone (9193)II
Levorphanol (9220)II
Meperidine (9230)II
Methadone (9250)II
Methadone Intermediate (9254)II
Metopon (9260)II
Dextropropoxyphene, bulk (9273)II
Morphine (9300)II
Thebaine (9333)II
Opium extracts (9610)II
Opium fluid extract (9620)II
Opium fluid extract (9620)II
Opium tincture (9630)II
Opium, powdered (9639)II
Opium, granulated (9640)II
Levo-alphacetylmethadol (9648)II
Oxymorphone (9652)II
Alfentanil (9737)II
Sufentanil (9740)II
Fentanyl (9801)II

The above cited Notice of Application contained an error in that the drug code for Oxycodone was listed as 9160 rather than 9143.

The firm plans to manufacture the listed controlled substances for internal use and for sale to other companies.

No comments or objections have been received. DEA has considered the factors in Title 21, United States Code, section 823(a) and determined that the registration of Mallinckrodt, Inc. to manufacture the listed controlled substances is consistent with the public interest at this time. DEA has investigated Mallinckrodt, Inc. to ensure that the company's registration is consistent with the public interest. This investigation has included inspection and testing of the company's physical security systems, verification of the company's compliance with state and local laws, and a review of the company's background and history. Therefore, pursuant to 21 U.S.C. 823 and 28 CFR 0.100 and 0.104, the Deputy Assistant Administrator, Office of Diversion Control, hereby orders that the application submitted by the above firm for registration as a bulk manufacturer of the basic classes of controlled substances listed is granted.

Start Signature

Dated: July 22, 2003.

Laura M. Nagel,

Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.

End Signature End Preamble

[FR Doc. 03-19814 Filed 8-4-03; 8:45 am]

BILLING CODE 4410-09-M